Research Priorities for HIV/M. tuberculosis Co-Infection

María Alejandra Alvarez1, Patricia Arbelaez2, Francisco Ignacio Bastos3, Ben Berkhout4, Basudev Bhattacharya5, Gennady Bocharov6, Valery Chereshnev7, Paloma Cuchí8, Martin Däumer9, Olga Demikhova10, Knut Feldmann11, Luis F. García2, Claudia Giehl12, Akash Gulalia13, Beate Kampmann14, Eduard Karamov15, Poloko Kebaabetswe16, Mikhail Kiselev17, Anne-Laure Knellwolf18, Afranio L. Kritski19, Christoph Lange20, Cecilio López-Galíndez21, Albert Makone22, Anandi Martin23, Harriet Mayanja-Kizza24, Ruth McNerney25, Andreas Meyerhans*, 26, Giovanni Battista Migliori27, Mariza G. Morgado3, Jean Nachega28, Bagrey Ngwira29, Michal Odermarsky30, Martin Ota31, Juan Carlos Palomino23, Gaby E. Pfyffer32, Wolfgang Preiser33, Viviana Ritacco1, Jaime Robledo34, Camilla Rodrigues35, Horacio Salomón36, Sofia Samper37, Jorge Sanchez38, Martina Sester39, Pradeep Seth40, Boniswa Seti41, Igor Sidorovich42, Rupak Singla43, Laure Sonnier30, Carlo Torti44, Enrico Tortoli45, Wim Vandevelde30, Stefano Vella18, Valdilea Veloso3, Hagen von Briesen46, Kamini Walia47, Gerhard Walzl33, Claire Wingfield48
1 CONICET, Argentina;
2 Universidad de Antioquia, Colombia;
3 FIOCRUZ, Brazil;
4 University of Amsterdam, AMC, The Netherlands;
5 Institute of Post-graduate Medical Education, India;
6 Institute of Numerical Mathematics, Russian Academy of Sciences, Russia;
7 Institute of Immunology and Physiology, Russian Academy of Sciences, Russia;
8 UNAIDS, Switzerland;
9 Institute of Immunology and Genetics, Germany;
10 Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Russia;
11 Kuratorium Tuberkulose in der Welt e.V., Germany;
12 European Research & Project Office, Germany;
13 BPS Women University, India;
14 Imperial College London, UK;
15 D.I. Ivanovsky Institute of Virology, Russian Academy of Medical Sciences, Russia;
16 BOTUSA, Botswana;
17 Ministry of Health and Social Development of the Russian Federation, Russia;
18 Istituto Superiore di Sanitá, Italy;
19 Federal University of Rio de Janeiro, Brazil;
20 Research Center Borstel, Germany;
21 Instituto de Salud Carlos III, Spain;
22 Community Working Group On Health, Zimbabwe;
23 Institute of Tropical Medicine, Belgium;
24 College of Health Sciences, Makerere University, Uganda;
25 London School of Hygiene & Tropical Medicine, UK;
26 Saarland University, Germany & ICREA and University Pompeu Fabra, Spain;
27 Fondazione Salvatore Maugeri, Italy;
28 Johns Hopkins University, USA;
29 Karonga Prevention Study, Malawi;
30 EATG, Belgium;
31 MRC, The Gambia;
32 Luzerne General Hospital, Switzerland;
33 Stellenbosch University, South Africa;
34 Corporación para Investigaciones Biológicas, CIB-UPB, Colombia;
35 Hinduja National Hospital, India;
36 Argentinean National Reference Center for AIDS, Argentina;
37 Instituto Aragonés de Ciencias de la Salud (I+CS), Spain;
38 Asociacion Civil Impacta, Salud y Educacion, Peru;
39 Saarland University, Germany;
40 Seth Research Foundation, India;
41 AIDS & RIGHTS Alliance for Southern Africa, South Africa;
42 SRC Institute of Immunology, Russia;
43 L.R.S. Institute of Tuberculosis & Respiratory Diseases, India;
44 University of Brescia, Italy;
45 Careggi University Hospital, Italy;
46 Fraunhofer IBMT, Germany;
47 Indian Council of Medical Research, India;
48 Treatment Action Group, USA

© 2011 Sester et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Correspondence: * Address correspondence to this author at the Department of Transplant and Infection Immunology, Institute of Virology, Saarland University, 66421 Homburg, Germany. Tel: 0049-6841-16-23557; Fax: 0049-6841-16- 21347; E-mail: or Infection Biology Laboratory, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain; Tel: 0034-933-160-831; E-mail:


This document summarizes priority areas for joint research and concerted actions to counteract the public health threat of AIDS/TB as identified within the European Support Action “EUCO-Net” funded under the 7th Framework Programme of the European Commission.

Keywords: Research priorities, pathogenesis, HIV/M. tuberculosis co-infection, treatment, prevention, diagnostics, EUCO-Net..